quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:50·41d
INSIDERFiling
Century Therapeutics Inc. logo

Chief Scientific Officer Cowan Chad covered exercise/tax liability with 1,431 shares, decreasing direct ownership by 0.12% to 1,177,045 units (SEC Form 4)

IPSC· Century Therapeutics Inc.
Health Care
Original source

Companies

  • IPSC
    Century Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Feb 25UpdateTD Cowen-
  • Aug 8UpdateRodman & Renshaw$6.00
  • Aug 28UpdateJP Morgan$5.00
  • Dec 27UpdateChardan Capital Markets$19.00
  • Oct 31UpdateGuggenheim$15.00
  • Oct 10UpdateCanaccord Genuity$28.00

Related

  • SEC7d
    SEC Form PRE 14A filed by Century Therapeutics Inc.
  • INSIDER13d
    SEC Form 4 filed by Murphy Martin Patrick
  • INSIDER13d
    SEC Form 3 filed by new insider Murphy Martin Patrick
  • INSIDER20d
    SEC Form 4 filed by Cowan Chad
  • SEC28d
    Century Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC28d
    SEC Form 424B5 filed by Century Therapeutics Inc.
  • INSIDER38d
    SVP Finance & Operations Carr Douglas sold $17,953 worth of shares (7,043 units at $2.55), decreasing direct ownership by 1% to 507,261 units (SEC Form 4)
  • INSIDER38d
    Officer Russotti Gregory sold $25,684 worth of shares (10,076 units at $2.55), decreasing direct ownership by 2% to 515,427 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022